Thymosin Alpha-1 for Immune Function & Defense — Immunity

Potent immunomodulator for enhancing immune function, fighting chronic infections, and supporting recovery from illness.

Overview

Thymosin Alpha-1 (TA-1) is a 28-amino acid peptide originally isolated from the thymus gland. It plays a critical role in T-cell maturation, immune system regulation, and inflammatory response modulation. With over 70 clinical trials and approval in 30+ countries (marketed as Zadaxin/Thymalfasin), TA-1 has demonstrated efficacy in chronic hepatitis, cancer adjuvant therapy, sepsis, and immune enhancement.

Indications

  • Chronic viral infections (hepatitis B/C, COVID-19)
  • Immune system optimization and disease prevention
  • Cancer adjuvant therapy during chemotherapy
  • Sepsis and severe acute infections
  • Vaccine response enhancement
  • Chronic fatigue and immune dysfunction

Mechanism of Action

Chronic viral infection, cancer, or immunosenescence impairs T-cell function and immune defense

Dosing

CompoundDoseFrequencyNotes
Thymosin Alpha-11.6 mgTwice weekly (e.g., Monday/Thursday)Standard wellness and prevention protocol
Thymosin Alpha-11.6 mgTwice weeklyDuration: 6-12 months for chronic hepatitis or persistent infections
Thymosin Alpha-11.6 mgTwice daily × 5 days, then once dailyFor sepsis or severe COVID-19, reduces mortality and restores lymphocyte counts
Thymosin Alpha-11.6 mgTwice weeklyThroughout chemotherapy or for 6 months, improves immune parameters
Thymosin Alpha-11.6 mgTwice weekly for 4-8 weeksGiven before/during vaccination to improve antibody response

Evidence Grade

GRADE B

Safety & Contraindications

  • Excellent safety profile with over 3,000 patients studied
  • Generally very well-tolerated with minimal side effects
  • Local injection site reactions (redness, mild discomfort) most common
  • Contraindicated in organ transplant recipients (may increase rejection risk)
  • Use with caution if immunocompromised - consult physician
  • Not FDA-approved in US but available via compounding pharmacies